Jackson Square Capital’s Boston Scientific BSX Stock Holding History

Jackson Square Capital’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-7,272	Closed	-$710K	–	155
2025 Q3	$710K	Sell	7,272 -49,034	-87%	-$5.08M	0.15%	89
2025 Q2	$6.05M	Buy	+56,306	New	+$5.7M	1.34%	25
2023 Q4	–	Sell	-10,867	Closed	-$574K	–	119
2023 Q3	$574K	Buy	10,867 +2,052	+23%	+$108K	0.23%	71
2023 Q2	$477K	Buy	8,815 +4,538	+106%	+$237K	0.19%	87
2023 Q1	$214K	Buy	+4,277	New	+$202K	0.1%	102
2021 Q4	–	Sell	-12,041	Closed	-$522K	–	189
2021 Q3	$522K	Buy	12,041 +3,492	+41%	+$154K	0.17%	110
2021 Q2	$366K	Buy	+8,549	New	+$360K	0.12%	140
2020 Q4	–	Sell	-316	Closed	-$12K	–	174
2020 Q3	$12K	Hold	316	–	–	0.01%	254
2020 Q2	$11K	Buy	+316	New	+$11.4K	0.01%	237
2020 Q1	–	Sell	-33,983	Closed	-$1.54M	–	326
2019 Q4	$1.54M	Buy	+33,983	New	+$1.42M	0.89%	40

Other funds holding BSX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Jackson Square Capital's BSX Position: Q4 2025 in Review

Jackson Square Capital sold out of Boston Scientific (BSX) in Q4 2025, closing a stake of 7,272 shares — an estimated $710K sold.

Jackson Square Capital first reported a position in BSX in Q4 2019 and held it in 10 quarters. The position peaked at $6.05M in Q2 2025. 1,783 funds tracked by Wall St. Rank hold BSX as of Q4 2025.

Jackson Square Capital reported no remaining Boston Scientific position as of Q4 2025 after selling out during the quarter.
Jackson Square Capital sold 7,272 Boston Scientific shares in Q4 2025, an estimated $710K.
Jackson Square Capital first reported a position in Boston Scientific in Q4 2019 and held it in 10 quarters.
Jackson Square Capital's Boston Scientific position peaked at $6.05M in Q2 2025.
1,783 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2025.

Based on Jackson Square Capital's 13F filing for Q4 2025, filed 21 Jan 2026.